Haemonetics Stock Market Value
| HAE Stock | USD 91.78 1.60 1.71% |
| Symbol | Haemonetics |
Haemonetics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.375 | Earnings Share 2.41 | Revenue Per Share 26.77 | Quarterly Revenue Growth 0.086 | Return On Assets 0.0588 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Haemonetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Haemonetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Haemonetics.
| 05/23/2023 |
| 11/13/2024 |
If you would invest 0.00 in Haemonetics on May 23, 2023 and sell it all today you would earn a total of 0.00 from holding Haemonetics or generate 0.0% return on investment in Haemonetics over 540 days. Haemonetics is related to or competes with Merit Medical, AngioDynamics, AptarGroup, Envista Holdings, Hologic, ICU Medical, and Cooper Companies,. Haemonetics Corporation, a healthcare company, provides medical products and solutions More
Haemonetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Haemonetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Haemonetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.32 | |||
| Information Ratio | 0.0914 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (2.02) | |||
| Potential Upside | 4.24 |
Haemonetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Haemonetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Haemonetics' standard deviation. In reality, there are many statistical measures that can use Haemonetics historical prices to predict the future Haemonetics' volatility.| Risk Adjusted Performance | 0.1386 | |||
| Jensen Alpha | 0.2191 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.1451 | |||
| Treynor Ratio | 0.4239 |
Haemonetics Backtested Returns
Haemonetics appears to be very steady, given 3 months investment horizon. Haemonetics holds Efficiency (Sharpe) Ratio of 0.17, which attests that the entity had a 0.17% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Haemonetics, which you can use to evaluate the volatility of the firm. Please utilize Haemonetics' Downside Deviation of 1.32, risk adjusted performance of 0.1386, and Market Risk Adjusted Performance of 0.4339 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Haemonetics holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of 0.83, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Haemonetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Haemonetics is expected to be smaller as well. Please check Haemonetics' total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether Haemonetics' current trending patterns will revert.
Auto-correlation | 0.38 |
Below average predictability
Haemonetics has below average predictability. Overlapping area represents the amount of predictability between Haemonetics time series from 23rd of May 2023 to 17th of February 2024 and 17th of February 2024 to 13th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Haemonetics price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Haemonetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 48.47 |
Haemonetics lagged returns against current returns
Autocorrelation, which is Haemonetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Haemonetics' stock expected returns. We can calculate the autocorrelation of Haemonetics returns to help us make a trade decision. For example, suppose you find that Haemonetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Haemonetics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Haemonetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Haemonetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Haemonetics stock over time.
Current vs Lagged Prices |
| Timeline |
Haemonetics Lagged Returns
When evaluating Haemonetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Haemonetics stock have on its future price. Haemonetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Haemonetics autocorrelation shows the relationship between Haemonetics stock current value and its past values and can show if there is a momentum factor associated with investing in Haemonetics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:Check out Haemonetics Correlation, Haemonetics Volatility and Haemonetics Alpha and Beta module to complement your research on Haemonetics. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.